877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

trc-canada.com, Nervous system drug

Categories

Drugs acting on the nervous system (5)
Pharmaceuticals (3)
Psychoactive drugs (3)
Cyclic compounds (2)
Psychopharmacology (2)
Alcohols (1)
Alpha blockers (1)
Alpha-2 blockers (1)
Antidepressants (1)
Antihistamines (1)
Antihypertensive agents (1)
Antiparkinsonian agents (1)
Antipsychotics (1)
Aromatic compounds (1)
Bromoarenes (1)
Cycloalkanes (1)
Cyclopropanes (1)
Dopamine antagonists (1)
Drugs acting on the cardiovascular system (1)
Drugs acting on the genito-urinary system (1)
Drugs for benign prostatic hyperplasia (1)
Fluoroarenes (1)
H1 receptor antagonists (1)
Monoamine oxidase inhibitors (1)
Monoamine releasing agents (1)
Noradrenergic and specific serotonergic antidepressants (1)
Norepinephrine-dopamine releasing agents (1)
Organic compound (1)
Phenethylamines (1)
Piperidines (1)
Six-membered rings (1)
Substituted amphetamines (1)
Tetracyclic antidepressants (1)
Three-membered rings (1)
Typical antipsychotics (1)
Urologicals (1)

Suppliers

Sigma Aldrich (3)
Accela (1)
AK Scientific (1)
Apollo Scientific (1)
Matrix Scientific (1)
Oakwood Chemical (1)
SynQuest Laboratories (1)
TCI Chemicals (1)

1-Aminocyclopropanecarboxylic acid (22059-21-8)  
1-aminocyclopropane-1-carboxylic acid  ·  1-aminocyclopropane-1-carboxylic acid, 14C-labeled  ·  ACC acid
1-Aminocyclopropane-1-carboxylic acid (ACC) is a disubstituted cyclic α-amino acid in which a three-membered cyclopropane ring is fused to the Cα atom of the amino acid. ACC plays an important role in the biosynthesis of the plant hormone ethylene. It is synthesized by the enzyme ACC synthase ( EC 4.4.1.14) from methionine and converted to ethylene by ACC oxidase (EC 1.14.17.4).
bromperidol (10457-90-6)  
R 11,333  ·  bromperidol, 82Br-labeled  ·  Tesoprel
Bromperidol (marketed as Bromidol, Bromodol) is a butyrophenone derivative. It is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia. It was discovered at Janssen Pharmaceutica in 1966.
4-Vinylbenzene-1,2-diol (6053-02-7)  
3,4-Dihydroxystyrene (DHS) is a centrally-acting inhibitor of the enzyme phenylalanine hydroxylase (PH). It is likely that DHS and other PH inhibitors will never have clinical applications on account of their capacity for inducing hyperphenylalaninemia and phenylketonuria.
1,3,5-tris(3-isocyanato-4-methylphenyl)-1,3,5-triazinane-2,4,6-trione (26603-40-7, 8060-82-0)  
brobenzoxaldine, broxyquinoline drug combination  ·  Intestopan  ·  Enteroquin
Aptiganel (137159-92-3)  
Aptiganel (Cerestat; CNS-1102) is an unsuccessful drug candidate which acts as a noncompetitive NMDA antagonist, and that was under development by Cambridge Neuroscience, Inc as a treatment for stroke. It has neuroprotective effects and was researched for potential use in the treatment of stroke, but despite positive results in animal studies, human trials showed limited efficacy, as well as undesirable side effects such as sedation and hallucinations, and clinical development was ultimately not continued. The drug's failure led to the collapse of Cambridge Neuroscience in 1998 and its eventual sale to CeNeS Pharmaceuticals in 2000.
temozolomide (85622-93-1)  
Temozolomide (TMZ; brand names Temodar and Temodal and Temcad) is an oral chemotherapy drug. It is an alkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.
Related searches
trc-canada.com
Nervous system drug